A Placebo-Controlled Adaptive Treatment Assignment Study of Intravenous COL-144 in the Acute Treatment of Migraine
Clinical trial NCT00384774 · COMPLETED
Trial details
- NCT number
- NCT00384774
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2007-06-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.